In vitro synergistic activity between 8-methoxypsoralen and ethambutol, isoniazid, and rifampin when used in combination against Mycobacterium tuberculosis

World Journal of Microbiology and Biotechnology

Volumn 26, Issue 4, 2010, Pages 623-628

  Ge, Fa ^a   Zeng, Fanli ^c   Guo, Na ^a   Fan, Junwen ^e   Song, Yu ^a   Liu, Siguo ^d   Wu, Xiuping ^a   Wang, Xuelin ^a   Deng, Xuming ^a   Jin, Qi ^b   Yu, Lu ^a  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

^d Harbin Veterinary Research Institute   (China)

^e BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

8 Methoxypsoralen; Antimycobacterial; Mycobacterium tuberculosis; Synergistic

Indexed keywords

ANTI-MYCOBACTERIAL; ANTIMYCOBACTERIAL ACTIVITY; CLINICAL DRUGS; CLINICAL ISOLATES; DRUG COMBINATIONS; DRUG-RESISTANT STRAINS; ETHAMBUTOL; IN-VITRO; INHIBITORY CONCENTRATION; M. TUBERCULOSIS; METHOXYPSORALEN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS STRAINS; NATURALLY OCCURRING; PLANT SPECIES; STANDARD STRAIN; SYNERGISTIC ACTIVITY;

BIOLOGICAL RADIATION EFFECTS; HYDRAZINE; MULTIOBJECTIVE OPTIMIZATION; STRAIN;

DRUG INTERACTIONS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77951092183     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-009-0214-0     Document Type: Article

References (24)

1. Bafi-Yeboa NFA, Arnason JT, Baker J et al (2005) Antifungal constituents of Northern prickly ash, Zanthoxylum americanum Mill. Phytomedicine 12: 370-377.
2. Berenbaum M, Feeny P (1981) Toxicity of angular furanocoumarins to swallowtail butterflies: Escalation in a coevolutiontary arms race? Science 212: 927-929.
3. Dardalhon M, Agoutin B, Watzinger M et al (2009) Slt2 (Mpk1) MAP kinase is involved in the response of Saccharomyces cerevisiae to 8-methoxypsoralen plus UVA. J Photochem Photobiol B 95: 148-155.
4. De Logu A, Onnis V, Saddi B et al (2002) Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis. J Antimicrob Chemother 49: 275-282.
5. De Logu A, Saddi M, Onnis V et al (2005) In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium. Int J Antimicrob Agents 26(1): 28-32.
6. Donald PR, van Helden PD (2009) The global burden of tuberculosis-combating drug resistance in difficult times. N Engl J Med 360(23): 2393-2395.
7. Dutt AK, Metha JB (1998) Chemotherapy of tuberculosis in developed countries. In: Gangadharan PRJ, Jenkins PA (eds) Mycobacteria. II. Chemotherapy. Chapman and Hall, New York, pp 131-160.
8. El Morrv AM (1968) Vitiligo and psoralens. Pergamon Press, New York.
9. Figueroa M, Rivero-Cruz I, Rivero-Cruz B et al (2007) Constituents, biological activities and quality control parameters of the crude extract and essential oil from Arracacia tolucensis var. multifida. J Ethnopharmacol 113(1): 125-131.
10. Hurdle JG, Lee RB, Budha NR et al (2008) A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents. J Antimicrob Chemother 62(5): 1037-1045.
11. Koenig R (2008) Drug-resistant tuberculosis: in South Africa, XDR TB and HIV prove a deadly combination. Science 319: 894-897.
12. Koenigs LL, Peter RM, Thompson SJ et al (1997) Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab Dispos 25: 1407-1415.
13. Kremer LS, Besra GS (2002) Current status and future development of antitubercular chemotherapy. Expert Opin Investig Drugs 11: 1033-1049.
14. Lin L, Londe H, Janda JM et al (1994) Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood 83: 2698-2706.
15. Mirando WS, Shiratsuchi H, Tubesing K et al (1992) Ultraviolet-irradiated monocytes efficiently inhibit the intracellular replication of Mycobacterium avium intracellulare. J Clin Invest 89(4): 1282-1287.
16. Newton SM, Lau C, Wright CW (2000) A review of antimycobacterial natural products. Phytother Res 14: 303-322.
17. Nunn P, Williams B, Floyd K et al (2005) Tuberculosis control in the era of HIV. Nat Rev Immunol 5: 819-826.
18. Oliva A, Lahoz E, Contillo R et al (1999) Fungistatic activity of Ruta graVeolens L extract and its allelochemicals. J Chem Ecol 25: 519-526.
19. Sage E, Bredberg A (1991) Damage distribution and mutation spectrum: the case of 8-methoxypsoralen plus UVA in mammalian cells. Mut Res 263: 217-222.
20. Stratton CW, Cooksey RC (1991) Susceptibility tests: special tests. In: Balows A, Hausler WJ, Herrmann KL (eds) Manual of clinical microbiology, 5th edn. American Society for Microbiology, Washington, pp 1153-1165.
21. World Health Organization (2007) Global tuberculosis control: surveillance, planning, financing. World Health Organization, Geneva.
22. Yoon YH, Jung KH, Sadun AA et al (2000) Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc. Toxicol Appl Pharmacol 162: 107-114.
23. Yoshimura M, Namura S, Akamatsu H et al (1996a) Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol 135(4): 528-532.
24. Yoshimura M, Namura S et al (1996b) Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol 135: 528-532.